AVITA Medical Inc (ASX:AVH)
AVITA Therapeutics is a regenerative medicine company with a technology platform to address unmet medical needs in burns, chronic wounds and aesthetics indications. Treatment solutions are derived from the regenerative properties of a patient’s own skin. RECELL is the company’s flagship product. In basic terms, RECELL can be used by doctors to ‘respray’ skin cells onto a patient suffering from some type of injury (e.g. a burn). The product takes a small amount of the patient’s skin as a sample and in around 30 minutes a spray can be created and applied.
AVITA Medical Inc (ASX:AVH) share price
AVITA Medical Inc (ASX:AVH) share price news
ASX 200 (INDEXASX:XJO) share prices follows US lower
A 3.8 per cent US inflation print contributed to a 0.4 per cent fall in the S&P/ASX 200 (INDEXASX: XJO).
Investing in ASX biotech ft. Dr Megan Baldwin & Jeremy Curnock Cook
Jeremy Curnock Cook of BioScience Managers and Dr Megan Baldwin of Opthea Ltd (ASX: OPT) join Owen Rask on The Australian Investors Podcast.
Is it time to buy Cathie Wood’s beaten-up biotech companies (BATS:ARKG)?
Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed biotech stocks have been beaten up mercilessly, so is now the time to buy?
ASX 200 morning report – AVH, SSG & IAG shares in focus
The S&P/ASX 200 (ASX:XJO) finished at another record on Wednesday. Avita (ASX:AVH) and Shaver Shop (ASX:SSG) shares are making headlines.
Q4 upgrade: Why the AVITA (ASX:AVH) share price is soaring
The AVITA Medical Inc (ASX:AVH) share price is soaring today, up 9%, after upgrading its FY21 fourth quarter expectations.
Why the AVITA (ASX:AVH) share price is booming
The AVITA Medical Inc (ASX:AVH) share price is up more than 14% after getting some positive news from the US FDA.
Avita (ASX:AVH) share price pushes higher on Q3 update
This morning, medical device developer Avita Medical Inc (ASX: AVH) released its Q3 FY21 results to the market. Here’s what happened.
Will the Avita (ASX:AVH) Q2 result regenerate its share price?
Avita Medical Inc (ASX: AVH) reports positive numbers in its second-quarter (Q2) of FY21. Is Avita on its way to restoring its share price to pre-COVID levels?
Avita Therapeutics (ASX:AVH) sinks 10% on BARDA update
The Avita Therapeutics Inc (ASX: AVH) share price was trading 10.53% lower today following an investor update to do with its BARDA partnership.